Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Ul Hassan, Najm
- Formulation of Ferrous Fumarate (Combination) Tablets by Using a Direct-Compression Method
Abstract Views :1148 |
PDF Views:147
Authors
Kishwar Sultana
1,
Najm Ul Hassan
2,
M. Shifa Khan
1,
Mohsin Abbas Khan
1,
Khadija Shahid
1,
Humaira Nadeem
1,
Junaid Umar Alvi
3
Affiliations
1 Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad-44000, PK
2 School of Pharmacy, University of Lahore Islamabad Campus, Islamabad, PK
3 Genera Pharmaceuticals, I-9/2 Islamabad, PK
1 Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad-44000, PK
2 School of Pharmacy, University of Lahore Islamabad Campus, Islamabad, PK
3 Genera Pharmaceuticals, I-9/2 Islamabad, PK
Source
Indian Journal of Science and Technology, Vol 3, No 9 (2010), Pagination: 994-1000Abstract
Ferrous fumarate has poor flow properties which cause compression problems. When ferrous fumarate is manufactured in combination with folic acid, the same problem is encountered. Therefore, a wet-granulation method is used for tablet manufacturing, which is a time-consuming and energy-wasting process compared to a directcompression method. In the present work, ferrous fumarate and folic acid (combination) tablets have been prepared using an optimized direct-compression technique that decreases the total manufacturing time of a batch (approx. 1.5 million tablets) from 24-28 h to only 2-3 h. The direct-compression technique is a simple and cost-effective method of manufacturing ferrous fumarate and folic acid (combination) tablets. Several formulations were developed using different proportions of avicel PH102, talcum, magnesium stearate, sodium lauryl sulfate, sugar, primojel, lactose, PVPK-30 and aerosil. Ten formulations were found to fulfill the specified criteria.Keywords
Ferrous Fumarate, Folic Acid, Tablets, Direct Compression, CombinationFull Text
References
- Armstrong NA (2002) Encyclopedia of pharmaceutical technology. Marcel Dekker, Inc., 03, 2723.
- Bailey LB and Berry RJ (2005) Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births and miscarriage. Am. J. Clin. Nutr. 81, 1213S-1217S.
- Bavitz JF, Bohidar NR and Restaino FA (1974) Disintegrability characteristics of three selected tablet excipients. Drug Dev. Commun. 1, 331-347.
- Beyer T, Day GM and Price SL (2001) The prediction, morphology and mechanical properties of the polymorphs of Paracetamol. J. Am. Chem. Soc. 123, 5086-5094.
- Billany MR (1980) Hydrophobicity of magnesium stearate and its effect on the dissolution rate of a model drug from solid dosage forms. Proc. 2nd Inter. Conf. on Pharm. Tech. Paris.
- Bolhuis GK, Smallenbroek AJ and Lerk CF (1981) Interaction of tablet disintegrants and magnesium stearate during mixing I: effect on tablet disintegration. J. Pharm. Sci. 70, 1328–1330.
- Bossert J and Stamm A (1980) Effect of mixing on the lubrication of crystalline lactose by magnesium stearate. Drug Dev. Ind. Pharm. 6, 573–589.
- Botto LD, Olney RS and Erickson JD (2004) Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am. J. Med. Genetics. 125C, 12-21.
- British pharmacopoeia (2004) The stationary office, London, A358. 2499,
- Butcher AE and Jones TM (1972) Some physical characteristics of magnesium stearate. J. Pharm. Pharmacol. 24, 1–9.
- Caldwell HC (1974) Dissolution of lithium and magnesium from lithium carbonate capsules containing Magnesium stearate. J. Pharm. Sci. 63, 770-773.
- Chilamkurti RN, Rhodes CT and Schwartz JB (1982) Some studies on compression properties of tablet matrices using a computerized instrumented press. Drug Dev. Ind. Pharm. 8, 63-86.
- Chowhan ZT, Amaro AA and Chow YP (1982) Tabletto- tablet dissolution variability and its relationship to the homogeneity of a water-soluble drug. Drug Dev. Ind. Pharm. 8(2), 145–168.
- Czeizel AE and Dudas I (1992) Prevention of the first occurrence of neural tube defects by preconceptional vitamin supplementation. J. Med. New Eng. 327, 1832-1835.
- Daly LE, Kirke PN, Malloy A, Weir D and Scott JM (1995) Folate levels and neural tube defects, implications for prevention. JAMA. 274, 1698-1702.
- Davidsson L, Kastenmayer P, Szajewska H, Hurrell RF and Barclay D (2000) Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. Am. J. Clin. Nutr. 71, 1597–1602.
- Enezian GM (1972) Direct compression of tablets using microcrystalline cellulose. Pharm. Acta. Helv. 47, 321-363.
- Garcia-Marquez MA, Munoz A and Jimenez- Castellanos MR (1992) The effect of two lubricants (Magnesium stearate & Pruv) in the formation of tablets of four anti-ulcer agents/by means of direct compression. Pharm. Acta. Helv. 67(2), 50-56.
- Gibson RS, Ferguson EL and Lehrfeld J (1998) Complementary foods for infant feeding in developing countries: their nutrient adequacy and improvement. Eur. J. Clin. Nutr. 52, 764–770.
- Goh YI, Bollano E, Einarson TR and Koren G (2006) Prenatal multivitamin supplementation and rates of congenital anomalies. A meta analysis. J. Obstet. Gynaecol. Can. 28, 680-689.
- Goh YI, Bollano E, Einarson TR and Koren G (2007) Prenatal multivitamin supplementation and rates of pediatric cancers, a meta-analysis. Clin. Pharmacol. Ther. 81, 685-691.
- Grexa RW and Parmentier CJ (1979) Cosmetic talc properties and specifications. Cosmet. Toilet. 94 (2), 29–33.
- Hand book of pharmaceutical excipients. 5th ed. (2006) 611-616.
- Hand book of pharmaceutical excipients. 5th ed. (2006) 687-689.
- Hanssen D et al. (1970) Evaluation of magnesium stearate as a tablet lubricating agent by electronic pressure measurements. Pharm. Ind. 32, 97-101.
- Hernier AP and Teleman O (1997) Interface between monoclinic crystalline cellulose and water: Break down of the odd even duplicity. Langmuir. 13, 511-518.
- Hollenbeck RG, Peck GE and Kildsig DO (1978) Application of immersional calorimetry in investigation of solid-liquid interactions: Microcrystalline cellulosewater system. J. Pharm. Sci. 67(11), 1599-1606.
- Hong-Guang W and Ru-Hua Z (1995) Compaction behaviour of paracetamol powders of different crystal. Int. J. Pharm. 21, 863-868.
- Hurrell RF, Furniss DE, Burri J, Whittaker P, Lynch SR and Cook JD (1989) Iron fortification of infant cereals: A proposal for the use of ferrous fumarate or ferrous succinate. Am. J. Clin. Nutr. 49, 1274–1282.
- Hurrell RF, Reddy MB, Burri J and Cook JD (2000) An evaluation of EDTA compounds for iron fortification of cereal-based foods. Br. J. Nutr. 84, 903–910.
- Hurrell RF, Reddy MB, Dassenko SA and Cook JD (1991) Ferrous fumarate fortification of a chocolate drink powder. Br. J. Nutr. 65, 271–283.
- Hussain MSH, York P and Timmins P (1992) Effect of commercial and high purity magnesium stearate on in vitro dissolution of paracetamol D.C tablets. Int. J. Pharm. 78, 203-207.
- Ibrahim and Olurinola (1991) Comparative microbial contamination levels in wet granulation and direct compression methods of tablet production. Pharm. Acta. Helv. 66, 293-301.
- Jivraj M, Martini LG and Thomson CM (2000) An overview of different excipients useful for the direct compression of tablets. Pharm. Sci. Technol. 3, 58-63.
- Khan KA and Rhodes CT (1973) Effect of different concentration on disintegration and compression characteristics of two insoluble direct compression systems. J. Pharm. Sci. 8(2), 77-80.
- Lachman L, Lieberman HA and Kanig JL (1976) The theory and practice of industrial pharmacy. 2nd edn., 347-348.
- Lamberson RF and Raynor GE (1976) Tableting properties of microcrystalline cellulose. Manuf. Chem. Aerosol News. 47(6), 55-61.
- Lerk CF and Bolhuis GK (1973) Comparative evaluation of excipients for direct compression I. Pharm. Weekbl. 108, 469-481.
- Lerk CF, Bolhuis GK and de Boer AH (1974) Comparative evaluation of excipients for direct compression II. Pharm. Weekbl. 109, 945-955.
- Lerk CF, Bolhuis GK and de Boer AH (1979) Effect of microcrystalline cellulose on liquid penetration in and disintegration of directly compressed tablets. J. Pharm. Sci. 68, 205-211.
- Marshal K and Sixsmith D (1974-75) Some physical characteristics of microcrystalline cellulose. Drug Dev. Commun. 1(1), 51-71.
- Martino PD, Joiris E and Martelli S (2004) Particle interaction of lubricated or un lubricated binary mixtures according to their particle size and densification mechanism II. Farmaco. 59, 747-758.
- Meredith C, Fidler Davidsson L, Zeder C, Walczyk T and Hurrell RF (2003) Iron absorption from ferrous fumarate in adult women is influenced by ascorbic acid but not by Na2EDTA. British J. Nutr. 90, 1081– 1085.
- MRC vitamin study research group: Prevention of neural tube defects: results of the medical research council vitamin study (1991) Lancet. 338,131-137.
- Nestel P, Briend A, De-Benoist B, Decker E, Ferguson E, Fontaine O, Micardi A, and Nalubola R (2003) Complementary food supplements to achieve micronutrient adequacy for infants and young children. J. Pediatr. Gastroenterol. Nutr. 36, 316–328.
- Nguyen P, Nava-Ocampo N, Levy A, Connor D, Einarson TR, Taddio A and Koren G (2008) Effect of iron content on the tolerability of prenatal multivitamins in pregnancy. BMC pregnancy childbirth. 8, 17.
- Omray A and Omray P (1986) Evaluation of microcrystalline cellulose as a glidant. Ind. J. Pharm. Sci. 48, 20-22.
- Pilpel N (1971) Metal stearates in pharmaceuticals and cosmetics. Manuf. Chem. Aerosol News. 42(10), 37–40.
- Prista LN, Alves AC and Morgado R (1995) Tecnologia farmaceutica, 5th ed. Fundacao Calouste Gulbenkian, Lisboa. 199-478.
- Remington: The science and practice of pharmacy (1995) 19th ed., 1038-1039.
- Shangraw RF (1989) Pharmaceutical dosage forms: Tablets. 01, Mercel Dekker. Inc. 109-164.
- Sheikh-Salem M and Fell JT (1981) The influence of magnesium stearate on time dependent strength changes in tablets. Drug Dev. Ind. Pharm. 7, 669–674.
- Tong K, Mitrebej T and Augsberger LL (1982) Adhesion of tablets in a rotary tablet press II. Effect of blending time, running time and lubricant concentration. Drug Develop. Indust. Pharm. 8(2), 237-282.
- UNICEF. The state of the world’s children. New York: UNICEF (2003)
- US Pharmacopoeia 30-NF25 (2007) 28, 618-619.
- Wallace JW, Capozzi JT and Shangraw RF (1983) Performance of pharmaceutical filler/binders as related to methods of powder characterization. Pharm. Technol. 7, 94-104.
- WHO Complementary feeding of young children in developing countries: a review of current scientific knowledge (1998) WHO. Nutr. 98.1. Geneva. WHO.
- Yasmeen R, Shoaib MH and Khalid H (2005) Comparative study of different formulations of atenolol. Pak. J. Pharm. Sci. 18, 49.
- Zhang Y, Law Y and Chakrabarti S (2003) Physical properties and compact analysis of commonly used direct compression binders. AAPS Pharm. Sci. Tech. 4, 1-11.